TBIOClinical Trialsglobenewswire

Tourmaline Bio Presents Data from the Ongoing Phase 2 TRANQUILITY Trial at the 2025 European Society of Cardiology Congress

Sentiment:Negative (30)

Summary

(TBIO) Tourmaline Bio Presents Data from the Ongoing Phase 2 TRANQUILITY Trial at the 2025 European Society of Cardiology Congress

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 31, 2025 by globenewswire